UK markets open in 18 minutes

ICAD May 2024 2.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.91000.0000 (0.00%)
As of 11:42AM EDT. Market open.
Full screen
Previous close0.9100
OpenN/A
Bid0.0000
Ask0.9000
Strike2.50
Expiry date2024-05-17
Day's range0.9100 - 0.9100
Contract rangeN/A
VolumeN/A
Open interest1
  • GuruFocus.com

    icad Inc (ICAD) (Q1 2024) Earnings Call Transcript Highlights: Strategic Growth and Operational ...

    Discover how icad Inc achieved a 14% revenue increase and improved operational metrics in the first quarter of 2024.

  • GlobeNewswire

    iCAD Reports Financial Results for First Quarter Ended March 31, 2024

    NASHUA, N.H., May 15, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three months ended March 31, 2024. First Quarter 2024 Highlights (Year over Year Performance): Total ARR was $9.0 million, up 10%Total revenues were $5.0 million, up 14%Gross Profit Margin % was 83%, up from 82%GAAP Net Loss from

  • GlobeNewswire

    UPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024

    Call Time is 8:30 AM Eastern TimeNASHUA, N.H., May 08, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial results for the first quarter ended March 31, 2024, pre-market and host a conference call at 8:30 AM Eastern Time on Wednesday, May 15, 2024. Earnings call details are as follows: Domestic: 877-545-0523International: 973-528-0016Participant Access Code: 730845Webcast: https: